A dose-ranging study to evaluate the antiretroviral activity and safety of amprenavir alone and in combination with abacavir in HIV-infected adults with limited antiretroviral experience.

Source:http://linkedlifedata.com/resource/pubmed/id/11491421

Download in:

View as

General Info

PMID
11491421